Tandem Investment Partners LLC Has $436,000 Position in UnitedHealth Group Incorporated $UNH

Tandem Investment Partners LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 21.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,397 shares of the healthcare conglomerate’s stock after buying an additional 250 shares during the period. Tandem Investment Partners LLC’s holdings in UnitedHealth Group were worth $436,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Citizens National Bank Trust Department lifted its position in shares of UnitedHealth Group by 1.0% in the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock worth $9,368,000 after purchasing an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH increased its stake in shares of UnitedHealth Group by 0.3% in the 1st quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Caitlin John LLC increased its stake in UnitedHealth Group by 14.8% during the 1st quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after purchasing an additional 111 shares in the last quarter. Triumph Capital Management bought a new stake in UnitedHealth Group during the 2nd quarter valued at $1,324,000. Finally, Wealth Effects LLC grew its stake in shares of UnitedHealth Group by 14.4% in the 2nd quarter. Wealth Effects LLC now owns 4,688 shares of the healthcare conglomerate’s stock worth $1,463,000 after acquiring an additional 591 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $360.17 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $326.20 billion, a P/E ratio of 15.61, a P/E/G ratio of 2.34 and a beta of 0.47. The business has a fifty day simple moving average of $307.84 and a two-hundred day simple moving average of $354.55. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the prior year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were given a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on UNH shares. Barclays upped their target price on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a research note on Thursday, September 4th. Sanford C. Bernstein boosted their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the stock an “outperform” rating in a report on Friday, September 5th. Piper Sandler cut their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating on the stock in a report on Wednesday, July 30th. Bank of America boosted their price target on shares of UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. Finally, Morgan Stanley upped their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Sixteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat, UnitedHealth Group has an average rating of “Hold” and a consensus target price of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.